Nurix Therapeutics, Inc. (NRIX)
25.79
-0.25
(-0.96%)
USD |
NASDAQ |
Sep 02, 16:00
25.79
0.00 (0.00%)
After-Hours: 19:41
Nurix Therapeutics Revenue (Annual) : 83.98M for Nov. 30, 2025
Revenue (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| November 30, 2025 | 83.98M |
| November 30, 2024 | 54.55M |
| November 30, 2023 | 76.99M |
| November 30, 2022 | 38.63M |
| Date | Value |
|---|---|
| November 30, 2021 | 29.75M |
| November 30, 2020 | 17.82M |
| November 30, 2019 | 31.12M |
| November 30, 2018 | 37.45M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Annual) Benchmarks
| Monte Rosa Therapeutics, Inc. | 123.67M |
| Gilead Sciences, Inc. | 29.45B |
| TG Therapeutics, Inc. | 616.29M |
| Cue Biopharma, Inc. | 27.47M |
| Keros Therapeutics, Inc. | 244.06M |